A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes

PHASE3CompletedINTERVENTIONAL
Enrollment

637

Participants

Timeline

Start Date

March 10, 2019

Primary Completion Date

November 22, 2019

Study Completion Date

November 22, 2019

Conditions
Dry Eye
Interventions
BIOLOGICAL

HL036 Ophthalmic Solution

HL036 Ophthalmic Solution

BIOLOGICAL

Placebo

Placebo vehicle solution

Trial Locations (12)

28150

Vita Eye Clinic, Shelby

30260

Eye Care Centers Management Inc, Morrow

33067

Specialty Retina Center, Coral Springs

33437

Specialty Retina Center, Boynton Beach

38119

Total Eye Care, P A, Memphis

40206

The Eye Care Institute, Louisville

46290

MidWest Cornea Associates, LLC, Indianapolis

85032

Cornea and Cataract Consultants of Arizona, Phoenix

90505

East West Eye Institute, Torrance

92663

Eye Research Foundation, Newport Beach

01810

Andover Eye Associates, Andover

02767

Andover Eye Associates, Raynham

All Listed Sponsors
collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

lead

HanAll BioPharma Co., Ltd.

INDUSTRY